Showing results (191-200 of 210) with videos related to
Sort By:
Pageof 21
Journal of Immunology Research|August 1, 2017
Polymorphism rs2073618 of the TNFRSF11B (OPG) Gene and Bone Mineral Density in Mexican Women with Rheumatoid ArthritisC A Nava-Valdivia, A M Saldaña-Cruz, E G Corona-Sanchez, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2016
Ex Vivo CD34+-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment ResponsePere Barba, Patrick Hilden, Sean M Devlin, et al.The Lancet. Haematology|December 3, 2025
Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 studyMichael Scordo, Miguel-Angel Perales, Audrey Mauguen, et al.Transplantation and Cellular Therapy|April 13, 2026
The Impact of Post-Transplant Interventions and Chronic GVHD on Survival in Myeloid Malignancies Harboring TP53 AlterationsMoataz Ellithi, Sandeep Raj, Maria Bromberg, et al.Blood Advances|December 8, 2020
High progression-free survival after intermediate intensity double unit cord blood transplantation in adultsJuliet N Barker, Sean M Devlin, Kristine A Naputo, et al.Transplantation and Cellular Therapy|May 25, 2021
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular TherapyCorrado Zuanelli Brambilla, Stephanie M Lobaugh, Josel D Ruiz, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 16, 2015
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host DiseaseRobert R Jenq, Ying Taur, Sean M Devlin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Intestinal Microbiota and Relapse After Hematopoietic-Cell TransplantationJonathan U Peled, Sean M Devlin, Anna Staffas, et al.Leukemia & Lymphoma|September 3, 2021
Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplantJan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, et al.Journal of Palliative Medicine|March 29, 2020
Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant RecipientsRichard J Lin, Abigail G Cohen, Stacy M Stabler, et al.Pageof 21